{"title":"Biogenic Calcium Mineral-Chitosan Composite Nanofiber Dressing for Control of Traumatic Hemorrhage","authors":"Pranabesh Kumar Sasmal, Shalini Dasgupta, Jerzy Kubacki, Samsamul Hoque, Samit Kumar Nandi, Abhijit Chanda, Pallab Datta","doi":"10.1002/jbm.b.35601","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Effective biomaterials for traumatic hemorrhage control remain an unmet clinical challenge, while several potential biomaterials, like oyster shell waste, are emerging as key ecological hazards. Hemostatic nanofiber dressing using biogenic calcium powders from <i>Magallana cuttackensis</i> is reported here. Extracted and treated powders were characterized by XRD, EDX, XPS, and Raman spectroscopy to confirm the presence of CaO and Ca(OH)<sub>2</sub> as the calcium phases. A chitosan-based nanofiber matrix, one of the most commonly used hemostatic dressing materials, was used as a control nanofiber (CNF) and integrated with shell waste calcium minerals (MSWNF). The hemolysis of CNF and MSWNF nanofibers was 5% ± 0.3% and 4% ± 0.2%, respectively. The in vitro clotting time (CT) under CNF and MSWNF nanofibers was 230 ± 11 s and 198 ± 4 s, which, along with other parameters—prothrombin times (27 ± 0.4 s and 22 ± 0.6 s) and plasma recalcification time (76 ± 4 s and 47 ± 1 s)—indicated enhancement in hemostasis performance by MSWNF over CNF. After in vivo evaluation in the rabbit incision model, the bleeding time of the control group (274 ± 6 s) was longer than CNF (97 ± 8 s) or MSWNF (75 ± 5 s). Blood oozing until hemostasis was 0.380 g, 0.354 g, and 0.121 g under control gauge, CNF, and MSWNF, respectively, demonstrating enhancement in hemostasis performance by MSWNF. Further, histopathological examination proved continued epithelialization and formation of capillaries, indicative of wound healing. The results provide promising evidence for a more effective biomaterial from biogenic oyster shell waste than commonly employed hemostatic dressing materials.</p>\n </div>","PeriodicalId":15269,"journal":{"name":"Journal of biomedical materials research. Part B, Applied biomaterials","volume":"113 6","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical materials research. Part B, Applied biomaterials","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jbm.b.35601","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Effective biomaterials for traumatic hemorrhage control remain an unmet clinical challenge, while several potential biomaterials, like oyster shell waste, are emerging as key ecological hazards. Hemostatic nanofiber dressing using biogenic calcium powders from Magallana cuttackensis is reported here. Extracted and treated powders were characterized by XRD, EDX, XPS, and Raman spectroscopy to confirm the presence of CaO and Ca(OH)2 as the calcium phases. A chitosan-based nanofiber matrix, one of the most commonly used hemostatic dressing materials, was used as a control nanofiber (CNF) and integrated with shell waste calcium minerals (MSWNF). The hemolysis of CNF and MSWNF nanofibers was 5% ± 0.3% and 4% ± 0.2%, respectively. The in vitro clotting time (CT) under CNF and MSWNF nanofibers was 230 ± 11 s and 198 ± 4 s, which, along with other parameters—prothrombin times (27 ± 0.4 s and 22 ± 0.6 s) and plasma recalcification time (76 ± 4 s and 47 ± 1 s)—indicated enhancement in hemostasis performance by MSWNF over CNF. After in vivo evaluation in the rabbit incision model, the bleeding time of the control group (274 ± 6 s) was longer than CNF (97 ± 8 s) or MSWNF (75 ± 5 s). Blood oozing until hemostasis was 0.380 g, 0.354 g, and 0.121 g under control gauge, CNF, and MSWNF, respectively, demonstrating enhancement in hemostasis performance by MSWNF. Further, histopathological examination proved continued epithelialization and formation of capillaries, indicative of wound healing. The results provide promising evidence for a more effective biomaterial from biogenic oyster shell waste than commonly employed hemostatic dressing materials.
期刊介绍:
Journal of Biomedical Materials Research – Part B: Applied Biomaterials is a highly interdisciplinary peer-reviewed journal serving the needs of biomaterials professionals who design, develop, produce and apply biomaterials and medical devices. It has the common focus of biomaterials applied to the human body and covers all disciplines where medical devices are used. Papers are published on biomaterials related to medical device development and manufacture, degradation in the body, nano- and biomimetic- biomaterials interactions, mechanics of biomaterials, implant retrieval and analysis, tissue-biomaterial surface interactions, wound healing, infection, drug delivery, standards and regulation of devices, animal and pre-clinical studies of biomaterials and medical devices, and tissue-biopolymer-material combination products. Manuscripts are published in one of six formats:
• original research reports
• short research and development reports
• scientific reviews
• current concepts articles
• special reports
• editorials
Journal of Biomedical Materials Research – Part B: Applied Biomaterials is an official journal of the Society for Biomaterials, Japanese Society for Biomaterials, the Australasian Society for Biomaterials, and the Korean Society for Biomaterials. Manuscripts from all countries are invited but must be in English. Authors are not required to be members of the affiliated Societies, but members of these societies are encouraged to submit their work to the journal for consideration.